Skip to main content
. 2016 Jul 8;11(7):e0158780. doi: 10.1371/journal.pone.0158780

Table 4. Compliance indicators.

Compliance Indicator 2012 2014 Overall
% (95% CI) % (95% CI) % (95% CI)
Febrile patients tested for malaria infection by RDT or microscopy 74.2% (58.7, 85.3) 81.1% (65.0, 90.8) 77.6% (67.2, 85.4)
Confirmed malaria cases prescribed recommended antimalarial/s 67.9% (46.9, 83.5) 63.8% (49.6, 79.5) 65.6% (54.2, 75.4)
Confirmed malaria cases not prescribed any antimalarial 0% 0% 0%
Presumptive/clinical/confirmed malaria cases prescribed recommended antimalarial/sa 26.5% (12.9, 46.6) 45.0% (35.8, 54.5) 33.7% (22.9, 46.6)
Confirmed non-malaria febrile illness cases prescribed an antimalarial 20.0% (9.7, 36.7) 10.6% (5.6, 19.2) 15.3% (9.2, 24.5)
Compliance with prescription protocols irrespective of diagnosis typeb 70.9% (55.1, 82.9) 85.1% (78.0, 90.2) 77.8% (68.7, 84.9)
Compliance with diagnostic and prescription protocolsc 58.0% (43.6, 71.2) 67.8% (55.7, 77.9) 62.8% (53.4, 71.3)

a. A presumptive malaria case is defined as any patient prescribed the recommended firstline antimalarial/s, despite no confirmatory diagnosis. A clinical malaria case is defined as any patient prescribed the recommended firstline antimalarial/s, despite testing negative for malaria via a diagnostic test.

b. Presumptive/clinical/confirmed malaria cases given the recommended firstline antimalarial/s and NMFI not treated with antimalarials. In this calculation, presumptive and clinical malaria diagnoses in which the recommended firstline antimalarial/s is prescribed are assumed to be correct.

c. In this calculation, presumptive and clinical diagnosis of malaria are assumed to be incorrect (non-compliant with protocol)